SNL Stock Overview
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Smith & Nephew plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£9.84 |
52 Week High | UK£13.16 |
52 Week Low | UK£8.88 |
Beta | 0.51 |
1 Month Change | -1.03% |
3 Month Change | -10.77% |
1 Year Change | -24.99% |
3 Year Change | -37.34% |
5 Year Change | -37.42% |
Change since IPO | 60.75% |
Recent News & Updates
Recent updates
Shareholder Returns
SNL | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | 0.6% | -2.8% | 1.4% |
1Y | -25.0% | -13.9% | 1.1% |
Return vs Industry: SNL underperformed the UK Medical Equipment industry which returned -13.9% over the past year.
Return vs Market: SNL underperformed the UK Market which returned 1.1% over the past year.
Price Volatility
SNL volatility | |
---|---|
SNL Average Weekly Movement | 3.1% |
Medical Equipment Industry Average Movement | 7.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: SNL has not had significant price volatility in the past 3 months.
Volatility Over Time: SNL's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1856 | 18,452 | Deepak Nath | www.smith-nephew.com |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Smith & Nephew plc Fundamentals Summary
SNL fundamental statistics | |
---|---|
Market cap | UK£8.58b |
Earnings (TTM) | UK£209.37m |
Revenue (TTM) | UK£4.42b |
41.0x
P/E Ratio1.9x
P/S RatioIs SNL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SNL income statement (TTM) | |
---|---|
Revenue | US$5.55b |
Cost of Revenue | US$1.66b |
Gross Profit | US$3.89b |
Other Expenses | US$3.63b |
Earnings | US$263.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.30 |
Gross Margin | 70.14% |
Net Profit Margin | 4.74% |
Debt/Equity Ratio | 55.3% |
How did SNL perform over the long term?
See historical performance and comparison